MS Contin Sustained-Release TabletsGeneric Name: Morphine
Examples include MS Contin and Oramorph SR
MS Contin Sustained-Release Tablets are used for:
Managing moderate to severe pain for more than a few days.
MS Contin Sustained-Release Tablets are a narcotic pain reliever. It works by dulling the pain perception center in the brain. It may also affect other body systems (eg, breathing and circulatory systems) at higher doses.
Do NOT use MS Contin Sustained-Release Tablets if:
- you are allergic to any ingredient in MS Contin Sustained-Release Tablets
- you have known or suspected paralysis of the intestines or antibiotic-associated colitis
- you have diarrhea due to poisoning, slowed breathing, severe asthma, or are having an asthma attack
Contact your doctor or health care provider right away if any of these apply to you.
Before using MS Contin Sustained-Release Tablets:
Some medical conditions may interact with MS Contin Sustained-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
- if you are pregnant, planning to become pregnant, or are breast-feeding
- if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
- if you have allergies to medicines, foods, or other substances
- if you have a history of drug abuse or dependence, have asthma, chronic obstructive pulmonary disease (COPD), or other lung or breathing problems
- if you have increased pressure in the head, recent head injury, or lesions in the head
- if you have difficulty urinating; heart, liver, or thyroid disease; hypercapnia (abnormally increased carbon dioxide tension in your arteries); curvature of the spine; seizures; or a history of suicidal thoughts or behaviors
- if you have low blood volume, a stomach blockage, inflammatory bowel disease, have had stomach tract surgery, or are in shock
Some MEDICINES MAY INTERACT with MS Contin Sustained-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:
- Fluoxetine, naltrexone, narcotic agonists/antagonists (eg, pentazocine), rifampin, or risperidone because they may decrease MS Contin Sustained-Release Tablets's effectiveness
- Barbiturate anesthetics (eg, thiopental), cimetidine, ethanol, ketorolac, sodium oxybate (GHB), or tricyclic antidepressants (eg, amitriptyline) because side effects such as CNS toxicity (disorientation, respiratory depression, seizures) may occur
- Barbiturate anesthetics (eg, thiopental) or sodium oxybate (GHB) because the risk of their side effects may be increased by MS Contin Sustained-Release Tablets
- Mexiletine or trovafloxacin because their effectiveness may be decreased by MS Contin Sustained-Release Tablets
This may not be a complete list of all interactions that may occur. Ask your health care provider if MS Contin Sustained-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
How to use MS Contin Sustained-Release Tablets:
Use MS Contin Sustained-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Take MS Contin Sustained-Release Tablets by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.
- Swallow MS Contin Sustained-Release Tablets whole. Do not break, crush, or chew before swallowing.
- Take MS Contin Sustained-Release Tablets on a regular schedule to get the most benefit from it. It is more effective in preventing pain than in treating pain after it occurs.
- If you also take trovafloxacin, do not take it within 4 hours before or after taking MS Contin Sustained-Release Tablets. Check with your doctor if you have questions.
- If MS Contin Sustained-Release Tablets are no longer needed, dispose of it as soon as possible. Ask your doctor or pharmacist how to dispose of MS Contin Sustained-Release Tablets properly.
- If you miss a dose of MS Contin Sustained-Release Tablets, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.
Ask your health care provider any questions you may have about how to use MS Contin Sustained-Release Tablets.
Important safety information:
- MS Contin Sustained-Release Tablets may cause dizziness or drowsiness. These effects may be worse if you take it with alcohol or certain medicines. Use MS Contin Sustained-Release Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.
- Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using MS Contin Sustained-Release Tablets; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.
- MS Contin Sustained-Release Tablets may cause constipation. Constipation may be avoided by using a stool softener or fiber laxative.
- The risk of MS Contin Sustained-Release Tablets becoming habit-forming may be greater if you take it in high doses or for a long time. Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.
- Tell your doctor or dentist that you take MS Contin Sustained-Release Tablets before you receive any medical or dental care, emergency care, or surgery.
- Do not take MS Contin Sustained-Release Tablets if you have had a severe allergic reaction to morphine or hydromorphone (such as MS Contin, Roxanol, Dilaudid). If you have a question about whether you are allergic to MS Contin Sustained-Release Tablets or if a certain medicine contains morphine or hydromorphone, contact your doctor or pharmacist.
- Lab tests may be performed while you use MS Contin Sustained-Release Tablets. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.
- Use MS Contin Sustained-Release Tablets with caution in the ELDERLY; they may be more sensitive to its effects.
- MS Contin Sustained-Release Tablets should not be used in CHILDREN; safety and effectiveness in children have not been confirmed.
- PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using MS Contin Sustained-Release Tablets while you are pregnant. MS Contin Sustained-Release Tablets are found in breast milk. Do not breast-feed while taking MS Contin Sustained-Release Tablets.
When used for long periods of time or at high doses, MS Contin Sustained-Release Tablets may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if MS Contin Sustained-Release Tablets stops working well. Do not take more than prescribed.
Some people who use MS Contin Sustained-Release Tablets for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction.
If you stop taking MS Contin Sustained-Release Tablets suddenly, you may have WITHDRAWAL symptoms. These may include anxiety; diarrhea; fever, runny nose, or sneezing; goose bumps and abnormal skin sensations; nausea; vomiting; pain; rigid muscles; rapid heartbeat; seeing, hearing or feeling things that are not there; shivering or tremors; sweating; and trouble sleeping.
Possible side effects of MS Contin Sustained-Release Tablets:
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Constipation; dizziness; drowsiness; exaggerated sense of well-being; headache; lightheadedness; nausea; restless mood; vomiting.Seek medical attention right away if any of these SEVERE side effects occur:
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); excessive drowsiness; fast or slow heartbeat; hallucinations; pounding in the chest; seizure; shock; shortness of breath; sudden chest pain; sweating; swelling of the face or throat.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects at http://www.fda.gov/medwatch.
If OVERDOSE is suspected:
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (http://www.aapcc.org), or emergency room immediately. Symptoms may include cold and clammy skin; convulsions; deep sleep; dizziness; drowsiness; lightheadedness; loss of consciousness; low body temperature; slowed breathing; slowed heartbeat.Proper storage of MS Contin Sustained-Release Tablets:
Store MS Contin Sustained-Release Tablets between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, light, and moisture. Do not store in the bathroom. Keep MS Contin Sustained-Release Tablets out of the reach of children and away from pets.
- If you have any questions about MS Contin Sustained-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.
- MS Contin Sustained-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.
- If your symptoms do not improve or if they become worse, check with your doctor.
This information is a summary only. It does not contain all information about MS Contin Sustained-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
- MS Contin Consumer Overview
- MS Contin Prescribing Information (FDA)
- MS Contin Detailed Consumer Information (PDR)
- Astramorph PF Prescribing Information (FDA)
- Avinza Consumer Overview
- Avinza Prescribing Information (FDA)
- Kadian Consumer Overview
- Kadian Prescribing Information (FDA)
- Oramorph SR Prescribing Information (FDA)